ClinicalTrials.gov
public full text
Public Domain
Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air
This study evaluates the change in the composition of Volatil Organic Compounds (VOC) in patients treated by monoclonal antibody for severe asthma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service#1058018
- Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients Responding to ICS Treatment#893091
- The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms#1103177
- Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children#1057953
- Fractional Exhaled Nitric Oxide and Exacerbations of COPD#1074890
Record · ID 917777
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive